JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
about
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.The JAK2 46/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies.The role of genotypes that modify the toxicity of chemical mutagens in the risk for myeloproliferative neoplasms.The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.Association between JAK2 rs4495487 Polymorphism and Risk of Budd-Chiari Syndrome in China.JAK2 inhibition for the treatment of hematologic and solid malignancies.Inherited predisposition to myeloproliferative neoplasmsThe JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients.JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms.
P2860
Q33828563-B67ED588-1E25-4F05-A398-738017195CD4Q35205659-D321E30C-D7B2-412E-9B30-9886C2131429Q35227976-6F3892A6-7394-4B2C-A640-EDA1A99CBACEQ35528622-B359CA93-EF92-4E41-9E57-8E8B3905748EQ36236231-CBB2FEE4-B0CB-4ED2-B8F7-3160FFB78E02Q38001733-05328F3F-9675-4017-8A14-B9C3AA442C54Q38127417-ADAF97A7-BF5B-47AC-BBD7-C1DD0028A32EQ42958719-2C0004A6-DA67-4A6A-95A2-E162B0134E90Q47690928-DACFFB58-8999-4826-9C21-50FC3991A8EEQ50453793-341E82C4-B0F2-434B-A47C-8ED996912B47Q54186062-20A6E16B-F70C-4DD7-A6A0-7DF7AFC6425FQ54969927-C4FBAE3F-D32F-443B-9484-90F601574633Q55069465-A8E01F79-C0A2-4775-8B38-ADF86FB0A5F3
P2860
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
@en
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
@nl
type
label
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
@en
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
@nl
prefLabel
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
@en
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.
@nl
P2093
P2860
P356
P1433
P1476
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
@en
P2093
H Andrikovics
J Varkonyi
P2860
P2888
P304
P356
10.1038/LEU.2010.172
P577
2010-09-02T00:00:00Z